Flash FinanceUS
After hours S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · KPET Ultra Paceline Corp (KPET)

KPET Ultra Paceline completes $200 million blank check IPO of 20 million units

Neutral Impact 3 of 5 financing Written later

KPET Ultra Paceline Corporation, a blank check company, completed its initial public offering of 20 million units at $10.00 per unit on April 1, 2026, generating $200 million in gross proceeds. The full $200 million was placed in a trust account, and the company states it has not selected a business combination target, so shareholders' capital is held for a future acquisition that has not yet been identified.

Key points

  • 20,000,000 units sold at $10.00 each, for gross proceeds of $200,000,000 on April 1, 2026
  • Concurrent private placement of 235,000 units at $10.00 each ($2,350,000) to KPET Ultra Paceline Unit Holdings, LLC
  • $200,000,000 placed in trust with Continental Stock Transfer & Trust Company, including $11,000,000 of deferred underwriting discounts and commissions
  • Company has not selected a business combination target; it has 24 months from the IPO closing, with one three-month extension at the sponsor's option

The filing

CompanyKPET Ultra Paceline Corp (KPET)
Form8-K, current report
Filed with the SECApr 7, 2026, 4:38 PM ET
Accession number0001213900-26-041088

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 07, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.